Skip to content

Penumbra Coil 400 4004C0620Recalls & reported problems

Penumbra, Inc. · PC400 Cplx XSft, 6x20 · Class 2 · Implant

All models of Penumbra Coil 400 (120)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI M4244004C06200), received between Jun 14, 2019 and Jun 14, 2019 — classified as 1 malfunction.

The most frequently reported specific device problem is “Failure to Fold” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Failure to Fold1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJun 14, 2019Failure to Fold; Failure to Fold

    THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE USING A PENUMBRA COIL 400 (PC400). DURING THE PROCEDURE, THE PHYSICIAN NOTICED THE PC400 WAS NOT FORMING AND THEREFORE, WAS REMOVED. THE PROCEDURE WAS SUCCESSFUL USING ANOTHER PC400 COIL. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 8701219 ↗

Other DEVICE, NEUROVASCULAR EMBOLIZATION devices

All DEVICE, NEUROVASCULAR EMBOLIZATION devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page